Market Cap ₹110 Cr.
Stock P/E 0.0
P/B 2.2
Current Price ₹44.2
Book Value ₹ 20
Face Value 10
52W High ₹57.9
Dividend Yield 0%
52W Low ₹ 34
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 25 | 77 | 79 | 110 | |
Other Income | 1 | 0 | 0 | 0 | |
Total Income | 26 | 78 | 80 | 111 | |
Total Expenditure | 21 | 71 | 71 | 98 | |
Operating Profit | 5 | 7 | 9 | 13 | |
Interest | 2 | 2 | 2 | 2 | |
Depreciation | 2 | 2 | 2 | 3 | |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 3 | 4 | 8 | |
Provision for Tax | 1 | 1 | 1 | 2 | |
Profit After Tax | 1 | 2 | 3 | 6 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 2 | 3 | 6 | |
Adjusted Earnings Per Share | 0.6 | 0.8 | 1.6 | 2.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 39% | 64% | 0% | 0% |
Operating Profit CAGR | 44% | 38% | 0% | 0% |
PAT CAGR | 100% | 82% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 22% | NA% | NA% | NA% |
ROE Average | 16% | 13% | 11% | 11% |
ROCE Average | 13% | 10% | 8% | 8% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 12 | 23 | 26 | 50 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 51 | 47 | 40 | 33 |
Other Non-Current Liabilities | 1 | 2 | 3 | 3 |
Total Current Liabilities | 25 | 32 | 44 | 83 |
Total Liabilities | 89 | 105 | 114 | 168 |
Fixed Assets | 46 | 44 | 39 | 35 |
Other Non-Current Assets | 7 | 5 | 4 | 8 |
Total Current Assets | 36 | 56 | 70 | 125 |
Total Assets | 89 | 105 | 114 | 168 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | -1 | 3 | 6 |
Cash Flow from Operating Activities | -9 | 0 | 10 | -20 |
Cash Flow from Investing Activities | -8 | -2 | 3 | 3 |
Cash Flow from Financing Activities | 15 | 6 | -10 | 13 |
Net Cash Inflow / Outflow | -2 | 4 | 3 | -5 |
Closing Cash & Cash Equivalent | -1 | 3 | 6 | 1 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0.58 | 0.84 | 1.63 | 2.45 |
CEPS(Rs) | 2.45 | 2.04 | 2.77 | 3.45 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 11.55 | 11.61 | 13.25 | 20.02 |
Core EBITDA Margin(%) | 17.57 | 8.65 | 10.83 | 11.61 |
EBIT Margin(%) | 12.45 | 6.22 | 8.48 | 9.43 |
Pre Tax Margin(%) | 5.13 | 3.39 | 5.35 | 7.21 |
PAT Margin (%) | 2.28 | 2.17 | 4.12 | 5.53 |
Cash Profit Margin (%) | 9.69 | 5.28 | 6.98 | 7.81 |
ROA(%) | 0.65 | 1.73 | 2.99 | 4.33 |
ROE(%) | 5 | 9.63 | 13.15 | 15.96 |
ROCE(%) | 4.95 | 7.01 | 9.29 | 12.67 |
Receivable days | 15.8 | 14 | 58.23 | 65.35 |
Inventory Days | 424.29 | 164.55 | 180.7 | 230.79 |
Payable days | 513.94 | 138.61 | 165.89 | 204.53 |
PER(x) | 0 | 0 | 0 | 10.67 |
Price/Book(x) | 0 | 0 | 0 | 1.3 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 2.51 | 0.88 | 0.75 | 0.97 |
EV/Core EBITDA(x) | 12.58 | 9.67 | 6.59 | 8.28 |
Net Sales Growth(%) | 0 | 205.16 | 2.87 | 39.1 |
EBIT Growth(%) | 0 | 52.6 | 40.23 | 54.63 |
PAT Growth(%) | 0 | 189.72 | 95.25 | 86.75 |
EPS Growth(%) | 0 | 44.86 | 95.25 | 49.59 |
Debt/Equity(x) | 4.51 | 2.16 | 1.7 | 0.86 |
Current Ratio(x) | 1.43 | 1.73 | 1.58 | 1.52 |
Quick Ratio(x) | 0.27 | 0.49 | 0.72 | 0.29 |
Interest Cover(x) | 1.7 | 2.2 | 2.71 | 4.25 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.66 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 71.69 | 71.69 | 71.69 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 28.31 | 28.31 | 28.31 |
Others | 0 | 0 | 0 |
Total | 100 | 100 | 100 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 1.79 | 1.79 | 1.79 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 0.71 | 0.71 | 0.71 |
Others | 0 | 0 | 0 |
Total | 2.5 | 2.5 | 2.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About